Skip to content

Efficacy and safety of electrothermal-electroacupuncture, electroacupuncture, and manual acupuncture in the treatment of knee osteoarthritis: A multicenter randomized controlled trial

Efficacy and safety of electrothermal-electroacupuncture, electroacupuncture, and manual acupuncture in the treatment of knee osteoarthritis: A multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002016
Enrollment
Unknown
Registered
2025-10-28
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Sham Acupuncture Group:Sham Acupuncture
Electroacupuncture Group:electroacupuncture
Electrothermal-Electroacupuncture Group:electrothermal-electroacupuncture

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Complies with KOA Western Medicine diagnosis 2) KL staging levels I-III; 3) NRS score = 4 points; 4) 40 years old = age = 75 years old; 5) Written informed consent; 6) Agree to avoid the routine use of analgesics.

Exclusion criteria

Exclusion criteria: 1) Assess whether the knee joint has undergone previous knee joint surgery or any knee joint is currently undergoing any surgery; 2) Knee joint pain caused by other pathological reasons (such as meniscus tears, rheumatoid arthritis, joint cavity infections, malignant tumors, gout, lumbar and sacral diseases with lower limb symptoms, etc.); 3) Evaluate whether there is a history of arthroscopic examination of the knee joint within 1 year or intra-articular injection within 6 months; 4) Any knee joint has received acupuncture and moxibustion therapy in the past 6 months; 5) Severe acute or chronic organic or neuropsychiatric disorders; 6) Coagulation disorders (such as hemophilia); 7) Pacemakers or epilepsy; 8) Preparation for pregnancy, pregnancy or lactation period; 9) I have participated in other clinical studies within the past month.

Design outcomes

Primary

MeasureTime frame
effective response rate;

Secondary

MeasureTime frame
effective response rate;Numeric Rating Scale, NRS;The WOMAC score: including the Total WOMAC score, WOMAC Pain score, WOMAC Stiffness score, and WOMAC Physical Function score.;Medical Outcomes Study 12-Item Short Form Health Survey (SF-12);Credibility/Expectancy Questionnaire, CEQ;Patient's global assessment, PGA;Thirty-second Chair Stand Test, 30s-CST;Gait Parameters and Range of Motion;Quadriceps Strength;

Countries

China

Contacts

Public ContactBin Li

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

libin@bjzhongyi.com18910781852

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026